TMEM183A Activators
TMEM183A activators in this context are chemical compounds that indirectly influence the activity of TMEM183A, a transmembrane protein with limited specific research available. These activators do not directly target TMEM183A but act on cellular processes and pathways that could impact its function.Firstly, chemicals like Cyclosporin A, Rapamycin, and Brefeldin A affect various cellular functions including immunosuppression, mTOR pathway inhibition, and Golgi apparatus disruption. These mechanisms could influence the signaling pathways and cellular trafficking processes that TMEM183A is involved in or dependent upon.
Additionally, agents such as Tunicamycin, Thapsigargin, and Chloroquine target protein glycosylation, ER stress, and endosomal pH, respectively. These processes are crucial for the proper functioning and localization of many transmembrane proteins, including potentially TMEM183A. Modulating these processes could indirectly affect TMEM183A's stability, localization, or function.Moreover, compounds like MG132, WZ4003, and Ionomycin interact with proteasome function, NUAK pathways, and calcium signaling, respectively. These interactions could create a cellular context where the activity or expression of TMEM183A is modified, as these pathways can be linked to the regulation of transmembrane proteins.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Immunosuppressant that could affect transmembrane protein signaling, potentially influencing TMEM183A. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor; may indirectly affect transmembrane proteins like TMEM183A. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Disrupts Golgi apparatus, could influence TMEM183A trafficking or function. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
ER stress inducer; might impact TMEM183A function through ER-associated degradation pathways. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Alters endosomal pH, potentially influencing TMEM183A localization or function. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor; could stabilize proteins in pathways associated with TMEM183A. | ||||||
WZ8040 | 1214265-57-2 | sc-364656 sc-364656A | 5 mg 10 mg | $255.00 $480.00 | ||
NUAK inhibitor; may indirectly influence pathways related to TMEM183A. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Calcium ionophore; could affect calcium signaling pathways involving TMEM183A. | ||||||
U 18666A | 3039-71-2 | sc-203306 sc-203306A | 10 mg 50 mg | $143.00 $510.00 | 2 | |
Inhibits cholesterol trafficking, potentially impacting TMEM183A in lipid rafts or related domains. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
ROCK inhibitor; might affect cytoskeletal dynamics, indirectly influencing TMEM183A. | ||||||